Computational platform expands genetic screening scope in high-consanguinity Gulf populations
This study describes the development and economic modeling of the SafeGene computational platform for predictive genetic screening. The analysis focuses on populations in Saudi Arabia and the Gulf region, which have high consanguinity rates (50-58%) and elevated carrier frequencies for certain recessive disorders. The platform is designed to screen for 50 genetic conditions across 12 categories, expanding upon the existing premarital screening program that screens for only two conditions.
The main results are based on platform validation and economic modeling. The platform demonstrated concordance with observed disease frequencies from published data. Economic modeling projects that implementing this expanded screening could prevent 2,800-4,200 affected births annually, with projected annual savings of SAR 1.2-2.8 billion ($320-746 million USD).
Safety and tolerability data were not reported. Key limitations include that the platform is described but not tested in a clinical population, and the projected prevented births and savings are from economic modeling rather than prospective implementation. Validation was performed against published data rather than through a prospective clinical study.
Practice relevance is not reported. The findings represent a theoretical expansion of screening scope and projected benefits based on modeling assumptions. Clinicians should interpret these projections cautiously as they are not derived from clinical trial evidence of platform implementation or patient outcomes.